Daniel Cohen

Analyst

Morgan Stanley

Equibles does not estimate personal net worth.

About Daniel Cohen

Daniel Cohen is recorded as Analyst at Morgan Stanley. Daniel Cohen has spoken on 2 investor events across 2 companies, most recently for Aptargroup, Inc. on September 15, 2026. Those appearances were for Aptargroup, Inc. (ATR) and Ani Pharmaceuticals Inc (ANIP). The companies whose calls Daniel Cohen spoke on are classified in the Healthcare sector.

Daniel Cohen on recent calls

“I'm a managing director at Morgan Stanley. It's my pleasure to host this fireside chat with the leadership of Aptar Group.”

Analyst — Morgan Stanley, Morgan Stanley 24th Annual Global Healthcare Conference · September 15, 2026

“A&I is a diversified biopharmaceutical company that has transformed itself into a rare disease growth story, led by Cortrofingel and a growing ophthalmology portfolio, supported by strong cash-generative generics and established brands and businesses.”

Analyst — Morgan Stanley, Morgan Stanley 24th Annual Global Healthcare Conference · September 14, 2026